NFKB1 and neoplasm: Following treatment with complex 3 (10 mg/kg body weight of mice), the expressions of angiogenic and metastatic markers such as VEGF and MMP-9 respectively were also inhibited (Figure 6, lower panel), indicating that tumor death occurs by activation of p53 and inhibition of the NF-κB protein, VEGF and MMP-9.